The purpose of this study is to create a database of information that allows researchers to explore how genetics and other biomarkers are impacted by bipolar disorder and its treatment.

An analysis of the FINEXT-BD data found that individuals with bipolar disorder have a 3.1% risk of cardiovascular events, ...

Two local research institutions have received a multimillion-dollar grant to join a national research network. The University ...

Exposure to greater lithium levels in drinking groundwater may be associated with a lower risk for cancers, a US cohort study ...

Recognizing stability in bipolar disorder is deeply personal. These are the signs that helped me understand what feeling ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

BMY is banking on new drugs to offset generic competition for older drugs. However, this might not be enough as the outlook ...

BioXcel said the Phase 3 trial is designed to evaluate the safety of BXCL501. The trial's topline-data results, which are expected in the second half of 2025, are intended to support a potential ...

While J&J is yet to give up on aticaprant, it decides to stop developing the drug for major depressive disorder due to a lack ...

Once the patient is stable and medical causes of an acute delirium have been eliminated, treatment of the psychiatric ... naming fewer than 18 animals in 1 minute) and visuospatial functioning ...

Many who escalate complaints get insurance denials overturned. Consumer advocates say that’s a clear sign companies routinely deny care they shouldn’t.

Iowa lawmakers have advanced legislation that would allow Iowa courts to order treatment for individuals showing psychiatric ...